Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 435,300 shares, an increase of 247.1% from the May 31st total of 125,400 shares. Based on an average daily volume of 1,880,000 shares, the short-interest ratio is currently 0.2 days. Approximately 2.7% of the shares of the stock are short sold.
Azitra Stock Down 30.2 %
Shares of Azitra stock traded down $0.04 during mid-day trading on Friday, hitting $0.09. 3,365,822 shares of the stock were exchanged, compared to its average volume of 3,520,313. The company has a quick ratio of 2.80, a current ratio of 2.80 and a debt-to-equity ratio of 0.01. Azitra has a twelve month low of $0.09 and a twelve month high of $4.33.
Azitra shares are going to reverse split on Monday, July 1st. The 1-30 reverse split was announced on Monday, July 1st. The number of shares owned by shareholders will be adjusted after the market closes on Monday, July 1st.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Featured Articles
- Five stocks we like better than Azitra
- How to Use the MarketBeat Dividend Calculator
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Investing in large cap stocks: Diving into big caps
- MarketBeat Week in Review – 6/24 – 6/28
- What Are Dividend Achievers? An Introduction
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.